The VALOR Study – A Clinical Trial for People Living with SOD1-ALS
The VALOR Study – A Clinical Trial for People Living with SOD1-ALS
Biogen is conducting a clinical trial to evaluate the safety and potential…
Stay in [u]touch[/u]

Stay in touch

Would you like to keep up to date with the latest news from TRICALS? Click on the button below to subscribe to our newsletter

Swimming the Catalan coast to raise funds for TRICALS
Swimming the Catalan coast to raise funds for TRICALS
To raise funds for TRICALS, Daniel Rossinés has taken on an epic…
CENTAUR phase 2 trial reveals promising results
CENTAUR phase 2 trial reveals promising results
New findings from the CENTAUR trial show that the drug ‘sodium phenylbutyrate–taurursodiol’…
Current developments in clinical trial design and conduct
Current developments in clinical trial design and conduct
Over 70 compounds have been evaluated by clinical studies, yet Riluzole is…
Reforming clinical studies for ALS
Reforming clinical studies for ALS
In order to find new treatments for ALS, our current strategy for…
The European Medicines Agency (EMA) endorses TRICALS’ innovative platform trial
The European Medicines Agency (EMA) endorses TRICALS’ innovative platform trial
TRICALS has received the exciting news that the European Medicines Agency (EMA)…
Second TRICALS Masterclass postponed
Second TRICALS Masterclass postponed
As a result of the continuing global uncertainty caused by the COVID-19…
Launch of our new TRICALS website
Launch of our new TRICALS website
We are pleased to announce the official launch of our brand-new TRICALS…